In a strategic move to reinforce its status as a global supplier of surgical instruments, Oury Medical announces the acquisition of Metal Global Concept (MGC) and Imprint Medical.
These two acquisitions mark a significant step in Oury Medical's transformation into a unique, vertically-integrated partner for surgical instrumentation, combining decades of cutting-instrument expertise with new capabilities in precision sheet metal containers and R&D-driven implant development.
Metal Global Concept (MGC)
For over 40 years, MGC has supported its customers in its core expertise of precision sheet metal work. Starting in 2018, the company developed tooling and an industrial organization focused on the development of containers for the medical segment.
The acquisition of MGC adds containers to Oury Medical's product range and enables the group to position itself as a unique partner for surgical instrumentation, covering instruments, ancillaries, and now containers as a complete offering.
Imprint Medical
Lyon-based Imprint Medical brings recognized expertise in the research and development of surgical implants and instruments. This acquisition strengthens Oury Medical's R&D capabilities across the value-creation chain, from design to mass production.
Combined, MGC and Imprint complete Oury Medical's transformation: from a century-old specialist in orthopedic instrumentation to a fully integrated platform serving the largest orthopedic groups in France and abroad.
Strategy: buy-and-build
These two add-on acquisitions follow Tioopo Capital's October 2022 platform investment in Oury Guye & Fils, a 100-year-old French medical instruments specialist, alongside SPE Capital. The integration of SMAO (Jan 2023), MGC (Oct 2023), and now Imprint Medical (Nov 2023) creates the Oury Medical group, positioned as a leading European partner for surgical instrumentation.